Urinary macromolecules and renal tubular cell protection from oxalate injury: Comparison of normal subjects and recurrent stone formers

International Journal of Urology

Volumn 13, Issue 3, 2006, Pages 197-201

  Tsujihata, Masao ^a,b   Tsujikawa, Kozo ^a   Tei, Norihide ^a   Yoshimura, Kazuhiro ^a   Okuyama, Akihiko ^a  

^a OSAKA UNIVERSITY   (Japan)

^b OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Calcium oxalate crystal; MDCK cell; Renal tubular cell injury; Urinary macromolecule

Indexed keywords

GLYCOSAMINOGLYCAN; LACTATE DEHYDROGENASE; OXALIC ACID;

ADULT; AGED; ANIMAL CELL; ARTICLE; CELL DAMAGE; CELL LINE; CELL PROTECTION; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOTOXICITY; ENZYME RELEASE; EPITHELIUM CELL; HUMAN; KIDNEY EPITHELIUM; KIDNEY TUBULE; MACROMOLECULE; MACROMOLECULE URINE LEVEL; MALE; MOLECULAR WEIGHT; NONHUMAN; PARAMETER; PRIORITY JOURNAL; RENAL PROTECTION; URINALYSIS; URINE LEVEL; UROLITHIASIS;

ADULT; AGED; ANIMALS; CALCIUM OXALATE; CELLS, CULTURED; DISEASE PROGRESSION; DOGS; GLYCOSAMINOGLYCANS; HUMANS; KIDNEY TUBULES; L-LACTATE DEHYDROGENASE; MACROMOLECULAR SUBSTANCES; MALE; MIDDLE AGED; PROGNOSIS; URINARY CALCULI;

EID: 33645457520     PISSN: 09198172     EISSN: 14422042     Source Type: Journal    
DOI: 10.1111/j.1442-2042.2006.01271.x     Document Type: Article

References (28)

1. Miller C Kennington L Cooney R et al. Oxalate toxicity in renal epithelial cells: characteristics of apoptosis and necrosis. Toxicol. Appl. Pharmacol. 2000 162 132 41.
2. Lieberthal W Levine JS. Mechanisms of apoptosis and its potential role in renal tubular epithelial cell injury. Am. J. Physiol. 1996 271 F477 88.
3. Scheid C Koul H Hill WA et al. Oxalate toxicity in LLC-PK1 cells: role of free radicals. Kidney Int. 1996 49 413 19.
4. Thamilselvan S Byer KJ Hackett RL Khan SR. Free radical scavengers, catalase and superoxide dismutase provide protection from oxalate-associated injury to LLC-PK1 and MDCK cells. J. Urol. 2000 164 224 9.
5. Riese RJ Mandel NS Wiessner JH Mandel GS Becker CG Kleinman JG. Cell polarity and calcium oxalate crystal adherence to cultured collecting duct cells. Am. J. Physiol. 1992 262 F177 84.
6. Verkoelen CF van der Boom BG Houtsmuller AB Schroder FH Romijn JC. Increased calcium oxalate monohydrate crystal binding to injured renal tubular epithelial cells in culture. Am. J. Physiol. 1998 274 F958 65.
7. Lieske JC Toback FG Deganello S. Sialic acid-containing glycoproteins on renal cells determine nucleation of calcium oxalate dihydrate crystals. Kidney Int. 2001 60 1784 91.
8. Miyake O Yoshimura K Tsujihata M et al. Possible causes for the low prevalence of pediatric urolithiasis. Urology 1999 53 1229 34.
9. Tsujihata M Miyake O Yoshimura K Kakimoto KI Takahara S Okuyama A. Fibronectin as a potent inhibitor of calcium oxalate urolithiasis. J. Urol. 2000 164 1718 23.
10. Tsujihata M Miyake O Yoshimura K Kakimoto K Takahara S Okuyama A. Comparison of fibronectin content in urinary macromolecules between normal subjects and recurrent stone formers. Eur. Urol. 2001 40 458 62.
11. Jong JGN Weaver RA Sambeek RL. Measuring urinary glycosaminoglycans in the presence of protein: an improved screening procedure for mucopolysaccharidoses based on dimethylenblue. Clin. Chem. 1992 38 803 7.
12. Hackett RL Shevock PN Khan SR. Madin-Darby canine kidney cells are injured by exposure to oxalate and to calcium oxalate crystals. Urol. Res. 1994 22 197 204.
13. Hackett RL Shevock PN Khan SR. Alterations in MDCK and LLC-PK1 cells exposed to oxalate and calcium oxalate monohydrate crystals. Scanning Microsc. 1995 9 587 96.
14. Scheid CR Koul HK Kennington L et al. Oxalate-induced damage to renal tubular cells. Scanning Microsc. 1995 9 1097 107.
15. Khan SR Shevock PN Hackett RL. Urinary enzymes and calcium oxalate urolithiasis. J. Urol. 1989 142 846 9.
16. Kurien TB Selvam R. Induction of lipid peroxidation in calcium oxalate stone formation. Indian J. Exp. Biol. 1989 27 450 3.
17. Koul H Kennington L Nair G Honeyman T Menon M Scheid C. Oxalate-induced initiation of DNA synthesis in LLC-PK1 cells, a line of renal epithelial cells. Biochem. Biophys. Res. Commun. 1994 205 1632 7.
18. Duncan-Achanzar KB Jones JT Burke MF Carter DE Laird HE 2nd. Inorganic mercury chloride-induced apoptosis in the cultured porcine renal cell line LLC-PK1. J. Pharmacol. Exp. Ther. 1996 277 1726 32.
19. Gardner AM Xu FH Fady C et al. Apoptotic vs. nonapoptotic cytotoxicity induced by hydrogen peroxide. Free Radic. Biol. Med. 1997 22 73 83.
20. Scheid C Koul H Hill WA et al. Oxalate toxicity in LLC-PK1 cells, a line of renal epithelial cells. J. Urol. 1995 155 1112 16.
21. Kohjimoto Y Kennington L Scheid CR Honeyman TW. Role of phospholipase A2 in the cytotoxic effects of oxalate in cultured renal epithelial cells. Kidney Int. 1999 56 1432 41.
22. Cao LC Honeyman T Jonassen J Scheid C. Oxalate-induced ceramide accumulation in Madin-Darby canine kidney and LLC-PK1 cells. Kidney Int. 2000 57 2403 10.
23. Kohjimoto Y Honeyman TW Jonassen J Gravel K Kennington L Scheid CR. Phospholipase A2 mediates immediate early genes in cultured renal epithelial cells: possible role of lysophospholipid. Kidney Int. 2000 58 638 46.
24. Miyake O Kakimoto K Tsujihata M Yoshimura K Takahara S Okuyama A. Strong inhibition of crystal-cell attachment by pediatric urinary macromolecules: a close relationship with high urinary citrate secretion. Urology 2001 58 493 7.
25. Ebisuno S Kohjimoto Y Tamura M Ohkawa T. Adhesion of calcium oxalate crystals to Madin-Darby canine kidney cells and some effects of glycosaminoglycans or cell injuries. Eur. Urol. 1995 28 68 73.
26. Yamaguchi S Yoshioka T Utsunomiya M et al. Heparin sulfate in the stone matrix and its inhibitory effect on calcium oxalate crystallization. Urol. Res. 1993 21 187 92.
27. Breborowicz A Polubinska A Moberly J Ogle K Martis L Oreopoulos D. Hyaluronan modifies inflammatory response and peritoneal permeability during peritonitis in rats. Am. J. Kidney Dis. 2001 37 594 600.
28. Tanhehco EJ Kilgore KS Naylor KB Park JL Booth EA Lucchesi BR. Reduction of myocardial infarct size after ischemia and reperfusion by the glycosaminoglycan pentosan polysulfate. J. Cardiovasc. Pharmacol. 1999 34 153 61.